Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-720P is a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family, specifically annotated as the 720th copy or variant within the human genome[2][5][6]. U6 snRNA itself is a highly conserved non-coding RNA component of the spliceosome, essential for the excision of introns from pre-mRNA in eukaryotic cells[1][3]. However, as a pseudogene, RNU6-720P does not encode a functional RNA product and is considered a non-functional genomic sequence arising from the duplication or retrotransposition of the ancestral U6 snRNA gene[4][5][6]. Such pseudogenes are abundant in genomes and serve as molecular fossils without known biological function, therapeutic relevance, or disease association[5][6]. There is no evidence linking RNU6-720P to drug interactions, biomarker roles, or safety considerations. Notes: - This entry is not a functional gene or biological drug target; it is a non-coding RNA pseudogene, hence the field "is_target" is false and "is_incorrect" is true for a therapeutic target query[2][5][6]. - There are no known biological functions, disease associations, or molecular interactions relevant to this specific pseudogene[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 720, pseudogene (RNU6-720P).